Related Experiment Video
Updated: Aug 3, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
Evidence that the low-incidence red cell antigens Rla and Lsa are identical
L Kornstad1, C A Green, P Sistonen
1Statens Institutt for Folkehelsa, National Blood Group Reference Laboratory, Oslo, Norway.
Low-incidence red blood cell antigens Ls(a+) and Rl(a+) were found to be identical. Further serological and immunoblotting tests confirmed this finding, clarifying red cell antigen identification.
Area of Science:
- Immunology
- Transfusion Medicine
- Genetics
Background:
- Red blood cell antigens play a crucial role in blood transfusion compatibility and are important in diagnosing certain medical conditions.
- Low-incidence antigens, present in a small percentage of the population, can cause significant challenges in blood matching.
- The Ls(a+) and Rl(a+) antigens have been historically considered separate entities, necessitating clear identification.
Purpose of the Study:
- To determine if the low-incidence red blood cell antigens Ls(a+) and Rl(a+) are identical.
- To provide clarity in red blood cell antigen classification and improve transfusion practices.
Main Methods:
- Testing of Ls(a+) and Rl(a+) red blood cells using a panel of antisera with antibodies to low-incidence antigens.
- Performing adsorption and elution tests to confirm serological findings.
- Utilizing immunoblotting with antibodies to glycophorin C and glycophorin D to investigate the molecular basis of the antigens.
Main Results:
- Serological testing with numerous antisera indicated that Ls(a+) and Rl(a+) antigens are identical.
- Adsorption and elution tests confirmed the identity of these two antigens.
- Immunoblotting results supported the conclusion by showing reactivity with antibodies to glycophorin C and glycophorin D.
Conclusions:
- The Ls(a+) and Rl(a+) red blood cell antigens are identical.
- This finding has implications for red blood cell typing, antibody screening, and transfusion management, particularly in populations where these antigens are present.
More Related Videos
08:40An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017